Market Access : : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / / Giuseppe Galliverti, Nicola Saraceni and Federico Lega.
If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect st...
Saved in:
VerfasserIn: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Milan, Italy : : Milano University Press,, 2023. |
Year of Publication: | 2023 |
Language: | Italian |
Physical Description: | 1 online resource (164 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993599263004498 |
---|---|
ctrlnum |
(CKB)4960000000467607 (NjHacI)994960000000467607 (EXLCZ)994960000000467607 |
collection |
bib_alma |
record_format |
marc |
spelling |
Galliverti, Giuseppe, author. Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega. Market Access. Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science Milan, Italy : Milano University Press, 2023. 1 online resource (164 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect storm, it has become a reality at least since the early years of the new century. The world in which access to the market, the introduction of innovation, and consolidation of sales were built around the supervision of regulatory processes and the share of voice towards the prescribers have become much more complex. A context that many define as VUCA (volatile, uncertain, complex, ambiguous). In this book, therefore, both the reasons that prompted Life Science companies to rethink their strategy by dedicating increasing attention to the political and institutional decision-makers of the Regions and the management of healthcare companies, and the internal organization to support and strengthen their "market access" capabilities. Through the different perspectives - academic, consultancy, managerial - of the three authors, the logic that has guided the "change of skin" of Life Science companies is explored, as the functional tools for market access, the different declinations that this activity has had in the sector, future scenarios and further evolutionary prospects, the connection with the other company functions - sales, marketing, medical management, institutional affairs, administration - and many technical aspects which are the heart of the skills and toolbox required of those who want to successfully develop a career right in the field of market access. Life sciences. Management. 979-1-255-10022-5 Lega, Federico, author. Saraceni, Nicola, author. |
language |
Italian |
format |
eBook |
author |
Galliverti, Giuseppe, Lega, Federico, Saraceni, Nicola, |
spellingShingle |
Galliverti, Giuseppe, Lega, Federico, Saraceni, Nicola, Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / |
author_facet |
Galliverti, Giuseppe, Lega, Federico, Saraceni, Nicola, Lega, Federico, Saraceni, Nicola, |
author_variant |
g g gg f l fl n s ns |
author_role |
VerfasserIn VerfasserIn VerfasserIn |
author2 |
Lega, Federico, Saraceni, Nicola, |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_sort |
Galliverti, Giuseppe, |
title |
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / |
title_sub |
Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / |
title_full |
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega. |
title_fullStr |
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega. |
title_full_unstemmed |
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / Giuseppe Galliverti, Nicola Saraceni and Federico Lega. |
title_auth |
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / |
title_alt |
Market Access. Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science |
title_new |
Market Access : |
title_sort |
market access : nuovi paradigmi manageriali e strumenti operativi per le imprese del life science (perché niente è più come prima) / |
publisher |
Milano University Press, |
publishDate |
2023 |
physical |
1 online resource (164 pages) |
isbn |
979-1-255-10022-5 |
callnumber-first |
H - Social Science |
callnumber-subject |
HD - Industries, Land Use, Labor |
callnumber-label |
HD31 |
callnumber-sort |
HD 231 G355 42023 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
650 - Management & public relations |
dewey-ones |
658 - General management |
dewey-full |
658 |
dewey-sort |
3658 |
dewey-raw |
658 |
dewey-search |
658 |
work_keys_str_mv |
AT gallivertigiuseppe marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescienceperchenienteepiucomeprima AT legafederico marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescienceperchenienteepiucomeprima AT saraceninicola marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescienceperchenienteepiucomeprima AT gallivertigiuseppe marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescience AT legafederico marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescience AT saraceninicola marketaccessnuoviparadigmimanagerialiestrumentioperativiperleimpresedellifescience |
status_str |
n |
ids_txt_mv |
(CKB)4960000000467607 (NjHacI)994960000000467607 (EXLCZ)994960000000467607 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Market Access : Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796653152439631872 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02916nam a2200337 i 4500</leader><controlfield tag="001">993599263004498</controlfield><controlfield tag="005">20230630064726.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230630s2023 it o 000 0 ita d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4960000000467607</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994960000000467607</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994960000000467607</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="1" ind2=" "><subfield code="a">ita</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HD31</subfield><subfield code="b">.G355 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">658</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Galliverti, Giuseppe,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Market Access :</subfield><subfield code="b">Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science (perché niente è più come prima) /</subfield><subfield code="c">Giuseppe Galliverti, Nicola Saraceni and Federico Lega.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Market Access. Nuovi paradigmi manageriali e strumenti operativi per le imprese del Life Science </subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Milan, Italy :</subfield><subfield code="b">Milano University Press,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (164 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">If the NHS and its healthcare companies have only recently become aware of being faced with a "new normality", and, therefore, of having to "shed their skin" to face the challenges connected to it, a new normality for Life Science companies, perhaps best described as a perfect storm, it has become a reality at least since the early years of the new century. The world in which access to the market, the introduction of innovation, and consolidation of sales were built around the supervision of regulatory processes and the share of voice towards the prescribers have become much more complex. A context that many define as VUCA (volatile, uncertain, complex, ambiguous). In this book, therefore, both the reasons that prompted Life Science companies to rethink their strategy by dedicating increasing attention to the political and institutional decision-makers of the Regions and the management of healthcare companies, and the internal organization to support and strengthen their "market access" capabilities. Through the different perspectives - academic, consultancy, managerial - of the three authors, the logic that has guided the "change of skin" of Life Science companies is explored, as the functional tools for market access, the different declinations that this activity has had in the sector, future scenarios and further evolutionary prospects, the connection with the other company functions - sales, marketing, medical management, institutional affairs, administration - and many technical aspects which are the heart of the skills and toolbox required of those who want to successfully develop a career right in the field of market access.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Life sciences.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Management.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">979-1-255-10022-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lega, Federico,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Saraceni, Nicola,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:04:25 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-05-13 19:27:32 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345558210004498&Force_direct=true</subfield><subfield code="Z">5345558210004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345558210004498</subfield></datafield></record></collection> |